Holen Sie sich die Stockscreener-App
6.53
1.44%
-0.08
Schlusskurs vom Vortag:
$6.61
Offen:
$6.63
24-Stunden-Volumen:
55,687
Relative Volume:
0.39
Marktkapitalisierung:
$244.66M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
130.60
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
-6.39%
1M Leistung:
-7.98%
6M Leistung:
-13.36%
1J Leistung:
+2.44%
1-Tages-Spanne:
$6.485
$6.71
1-Wochen-Bereich:
$6.485
$7.165
52-Wochen-Spanne:
$4.76
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.53 | 247.65M | 128.45M | 6.54M | -8.79M | 0.05 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.82 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
114.68 | 48.74B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.05 | 44.85B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.78 | 34.12B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
536.19 | 23.35B | 3.13B | 1.27B | 1.12B | 26.39 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Eingeleitet | William Blair | Outperform |
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum - The Manila Times
Lifecore Biomedical, Inc. to Announce Q4 and Transition Period Financial Results on March 16, 2026 - Quiver Quantitative
Lifecore Biomedical to Report Financial Results for the - GlobeNewswire
Ideas Watch: Is Lifecore Biomedical Inc forming bullish engulfing patternsLayoff News & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment - Sahm
Lifecore Sets 2026 Annual Meeting, Proposal Deadlines - TipRanks
Lifecore to manufacture acne treatment batches for Indomo - Investing.com Nigeria
Lifecore to manufacture acne treatment batches for Indomo By Investing.com - Investing.com Australia
Lifecore Biomedical signs new agreement with Indomo to support innovative drug/device combination acne treatment - marketscreener.com
Lifecore Biomedical Signs New Agreement with Indomo to - GlobeNewswire
2026-03-03 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (LFCR) grants 30,000 RSUs to legal chief - Stock Titan
(LFCR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Market Fear: Is Lifecore Biomedical Inc currently under institutional pressureSwing Trade & Smart Money Movement Tracker - baoquankhu1.vn
LFCR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
LFCR Should I Buy - Intellectia AI
LFCR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
2026-02-22 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
2026-02-19 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect | NDAQ:LFCR | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - ACCESS Newswire
Price-Driven Insight from (LFCR) for Rule-Based Strategy - Stock Traders Daily
Lifecore Biomedical (NASDAQ:LFCR) Shares Up 1.4%Should You Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical to Participate at DCAT Week 2026 - Bitget
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc. a top pick in the sectorJuly 2025 Retail & Free Verified High Yield Trade Plans - mfd.ru
Will Lifecore Biomedical Inc. (LDE) stock beat Nasdaq index returnsPrice Action & AI Based Buy and Sell Signals - mfd.ru
Can Lifecore Biomedical Inc. (LDE) stock sustain breakout momentum2025 Trade Ideas & Free Community Consensus Stock Picks - mfd.ru
Aug Reactions: Is Lifecore Biomedical Inc. in a bullish channelTrade Entry Report & Technical Entry and Exit Alerts - mfd.ru
2026-02-12 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Why Lifecore Biomedical Inc. stock remains on watchlists2025 Year in Review & Smart Investment Allocation Insights - mfd.ru
Quarterly Earnings: Will Lifecore Biomedical Inc. stock hit new highs in YEAR2025 Analyst Calls & Weekly Setup with High ROI Potential - mfd.ru
Does Lifecore Biomedical Inc. stock benefit from AI growthTrade Risk Assessment & Capital Efficiency Focused Strategies - mfd.ru
Will Lifecore Biomedical Inc. (LDE) stock see valuation expansionQuarterly Profit Review & Free Expert Verified Stock Movement Alerts - mfd.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
(LFCR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Aug Reactions: What drives Lifecore Biomedical Incs stock priceMarket Volume Report & High Return Stock Watch Alerts - baoquankhu1.vn
Lifecore Biomedical (LFCR) Receives a Buy from Craig-Hallum - The Globe and Mail
2026-02-01 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Can Lifecore Biomedical Inc continue delivering strong returnsJuly 2025 Selloffs & Smart Allocation Stock Tips - baoquankhu1.vn
Market Recap: Is OPTT vulnerable to short sellersRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Portfolio Shifts: Is Lifecore Biomedical Inc a strong candidate for buy and holdIndex Update & Risk Controlled Swing Alerts - baoquankhu1.vn
Notice to Long-Term Shareholders of Lifecore Biomedical, - GlobeNewswire
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
2026-01-29 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
Is Lifecore Biomedical Inc. a defensive stockTrade Entry Summary & Free Community Supported Trade Ideas - mfd.ru
(LFCR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lifecore Biomedical (NASDAQ:LFCR) Trading 2.8% HigherHere's Why - MarketBeat
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
1.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):